Fig. 4From: Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study)Time by group analysis for all-drugs intake from baseline to month 12. Notes. A, All-drugs intake between baseline and month 12; B, Decrease in all-drugs intake from baseline to month 3, 6 and 12Back to article page